Phosphoric Acid

Phosphoric Acid

SCHEMBL2155206

O=P(O)(O)O.Oc1cn(Cl)c2ccccc12

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.38
ALDH1A1 P00352 7/20 0.38
KMT2A Q03164 4/20 0.38
MAPT P10636 4/20 0.38
MEN1 O00255 3/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HTT P42858 3/20 0.33
POLB P06746 2/20 0.33
IDO1 P14902 1/20 0.33
MITF O75030 1/20 0.33
LMNA P02545 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
PTPN1 P18031 1/20 0.33
HPGD P15428 2/20 0.32
HTR6 P50406 1/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
CYP2C19 P33261 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL151528 0.90 IDO1 (0.40) KDM4EALDH1A1KMT2AMAPTMEN1
Phosphoric Acid SCHEMBL6338665 0.78 ALDH1A1 (0.49) KDM4EALDH1A1KMT2AMAPTMEN1
Phosphoric Acid SCHEMBL5664380 0.78 KDM4E (0.37) KDM4EALDH1A1KMT2AMAPTMEN1
Phosphoric Acid SCHEMBL7800036 0.76 HPGD (0.39) ALDH1A1MAPTHTTIDO1LMNA
SCHEMBL272098 0.71 KDM4E (0.35) KDM4EALDH1A1KMT2AMAPTMEN1
SCHEMBL28287733 0.70 BAZ2B (0.38) KDM4EALDH1A1KMT2AMAPTMEN1
SCHEMBL20574565 0.70 KDM4E (0.33) KDM4EALDH1A1KMT2AMAPTMEN1
SCHEMBL28852179 0.70 IDO1 (0.40) KDM4EALDH1A1KMT2AMAPTMEN1
SCHEMBL2246479 0.69 KDM4E (0.32) KDM4ESMN1; SMN2LMNA
SCHEMBL28024648 0.68 AKR1C3 (0.49) KDM4EALDH1A1KMT2AMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10379015-B2 Method for labeling concentration density differentials of an analyte in a biological sample DIAGNOSTIC BIOSYSTEMS (US) 2019-08-13 US claimed
US-20180348099-A1 METHOD FOR LABELING CONCENTRATION DENSITY DIFFERENTIALS OF AN ANALYTE IN A BIOLOGICAL SAMPLE DIAGNOSTIC BIOSYSTEMS (US) 2018-12-06 US claimed
EP-2519645-B1 A culture medium for screening or enrichment of methicillin-resistant S. aureus BIO RAD INNOVATIONS (FR) 2018-08-22 EP claimed
US-9434978-B2 Culture medium for screening or enrichment of methicillin-resistant S. aureus BIO-RAD INNOVATIONS (FR) 2016-09-06 US claimed
US-20120322098-A1 CULTURE MEDIUM FOR SCREENING OR ENRICHMENT OF METHICILLIN-RESISTANT S. AUREUS BIO-RAD INNOVATIONS (FR) 2012-12-20 US claimed
EP-2519645-A1 A CULTURE MEDIUM FOR SCREENING OR ENRICHMENT OF METHICILLIN-RESISTANT S. AUREUS Bio-Rad Innovations (FR) 2012-11-07 EP claimed
WO-2011080305-A1 A CULTURE MEDIUM FOR SCREENING OR ENRICHMENT OF METHICILLIN-RESISTANT S. AUREUS BIO-RAD PASTEUR (FR) 2011-07-07 WO claimed
EP-0922112-A4 FORMAZAN-BASED IMMUNOASSAY KIRKEGAARD & PERRY LAB INC (US) 2000-07-12 EP claimed
EP-0922112-A1 FORMAZAN-BASED IMMUNOASSAY Kirkegaard & Perry Laboratories, Inc. (US) 1999-06-16 EP claimed
WO-1997042342-A1 FORMAZAN-BASED IMMUNOASSAY KIRKEGAARD & PERRY LABORATORIES, INC. (US) 1997-11-13 WO claimed
WO-1992021974-A1 STABLE ALKALINE PHOSPHATASE COMPOSITIONS WITH COLOR ENHANCEMENT AND THEIR USE IN ASSAYS QUIDEL CORPORATION (US) 1992-12-10 WO claimed
US-10379015-B2 Method for labeling concentration density differentials of an analyte in a biological sample DIAGNOSTIC BIOSYSTEMS (US) 2019-08-13 US disclosed
US-20180348099-A1 METHOD FOR LABELING CONCENTRATION DENSITY DIFFERENTIALS OF AN ANALYTE IN A BIOLOGICAL SAMPLE DIAGNOSTIC BIOSYSTEMS (US) 2018-12-06 US disclosed
EP-2519645-B1 A culture medium for screening or enrichment of methicillin-resistant S. aureus BIO RAD INNOVATIONS (FR) 2018-08-22 EP disclosed
US-9434978-B2 Culture medium for screening or enrichment of methicillin-resistant S. aureus BIO-RAD INNOVATIONS (FR) 2016-09-06 US disclosed
US-20120322098-A1 CULTURE MEDIUM FOR SCREENING OR ENRICHMENT OF METHICILLIN-RESISTANT S. AUREUS BIO-RAD INNOVATIONS (FR) 2012-12-20 US disclosed
EP-2519645-A1 A CULTURE MEDIUM FOR SCREENING OR ENRICHMENT OF METHICILLIN-RESISTANT S. AUREUS Bio-Rad Innovations (FR) 2012-11-07 EP disclosed
WO-2011080305-A1 A CULTURE MEDIUM FOR SCREENING OR ENRICHMENT OF METHICILLIN-RESISTANT S. AUREUS BIO-RAD PASTEUR (FR) 2011-07-07 WO disclosed